%A Stiasny,Karin %A Weseslindtner,Lukas %A Heinzel,Andreas %A Camp,Jeremy V. %A Oberbauer,Rainer %A Reindl-Schwaighofer,Roman %D 2022 %J Transplant International %C %F %G English %K Covid-19,kidney transplantation,antiviral,prophylaxis,SARS-CoV2 %Q %R 10.3389/ti.2022.10906 %W %L %M %P %7 %8 2022-December-12 %9 Letter to the Editor %# %! efficacy of mABs against SARS-COV-2 BA.1 and BA.2 in KTR %* %< %T SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab %U https://www.frontierspartnerships.org/articles/10.3389/ti.2022.10906 %V 35 %0 JOURNAL ARTICLE %@ 1432-2277